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ABSTRACT  
 
Individuals participating in biobanks and other large research projects are increasingly asked to 
provide broad consent for open-ended research use and widespread sharing of their biosamples 
and data.  We assessed willingness to participate in a biobank using different consent and data 
sharing models, hypothesizing that willingness would be higher under more restrictive scenarios.  
Perceived benefits, concerns and information needs, were also assessed.  In this experimental 
survey, individuals from 11 US healthcare systems in the Electronic Medical Records and 
Genomics (eMERGE) Network were randomly allocated to one of three hypothetical scenarios: 
tiered consent and controlled data sharing; broad consent and controlled data sharing; broad 
consent and open data sharing.  Of 82,328 eligible individuals, exactly 13,000 (15.8%) completed 
the survey.  Overall, 66% (95% CI: 63-69%) of population-weighted respondents stated they would 
be willing to participate in a biobank; willingness and attitudes did not differ between respondents 
in the three scenarios.  Willingness to participate was associated with self-identified White race, 
higher educational attainment, lower religiosity, perceiving more research benefits, fewer concerns, 
and fewer information needs. Most (86%, CI: 84-87%) participants would want to know what would 
happen if a researcher misused their health information; fewer (51%, CI: 47-55%) would worry 
about their privacy.  The concern that the use of broad consent and open data sharing could 
adversely affect participant recruitment is not supported by these findings.  Addressing potential 
participants’ concerns and information needs, and building trust and relationships with 
communities, may increase acceptance of broad consent and wide data sharing in biobank 
research.  
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INTRODUCTION 
 
Health research increasingly requires very large numbers of participants to be willing to share their 
biological samples, genomic data, and clinical information with researchers.1  The proposed 
Precision Medicine Initiative (PMI) is one prominent example of a very large biobank created to 
improve understanding of human health and disease.2; 3  In this type of biobank, participants are 
asked to share their data not only with the institutions making the request but also with other 
investigators at diverse sites, often for projects not yet conceived.4  The National Institutes of 
Health (NIH) Genomic Data Sharing Policy already requires that NIH-funded researchers 
proposing to generate genomic data obtain broad consent from participants, that is, consent that 
permits wide data sharing.5  
Obtaining broad consent has also been proposed by the Department of Health and Human 
Services and the White House Office of Science and Technology Policy as the preferred approach. 
Their 2015 Notice of Proposed Rulemaking (NPRM) required that informed consent be obtained 
for all research using tissue samples and most clinical data, and stated that such consent can be 
obtained in a one-time, open-ended or ‘broad’ fashion.6 
Obtaining broad consent from participants in biobanks reduces administrative burdens and 
may accelerate discovery.5  However, broad consent and wide data sharing reduces participants’ 
control over how their data is used.7; 8  Individuals who object to decreased control may be less 
willing to take part in the research.9-13   
Decreased willingness to participate in research is of particular concern for populations who 
are already underrepresented in medical research.  Most genomics research to date has used data 
predominantly from individuals of Northern European ancestry, limiting the insights gained for 
individuals of other ancestries.14-18  Ancestry is only imperfectly correlated with the social 
constructs of race and ethnicity, but this association does mean that perspectives on research 
participation within underserved groups can influence inclusion from underrepresented ancestry 
groups. Some racial and ethnic groups, including African-Americans, have less trust in medical 
researchers than others,19; 20 so that the move towards broad consent could undermine much-
needed efforts to increase participation in medical research among underrepresented groups. 
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Members of the public are key stakeholders in this discussion.21  A recent systematic 
literature review22 reported that, when presented with different consent models and asked to 
choose among them, individuals often favor greater levels of control and select more specific types 
of consent over broad consent.23-25  These findings could have serious implications for large-scale 
research efforts.  Asking respondents to choose from among several consent or data sharing 
options is quite different, however, from asking them to enroll in a particular biobank with a defined 
data sharing policy.  In addition, it is unclear whether respondents to these previous surveys truly 
understood the trade-offs involved, or whether they were simply endorsing the idea of greater 
choice more generally.  As noted in the same review, previous studies have also tended to be 
small and local, and underrepresent key demographic groups.22    
We therefore conducted a large survey of attitudes towards consent and data sharing in 
biobank research among diverse participants recruited at multiple healthcare systems participating 
in the Electronic Medical Records and Genomics (eMERGE) Network.26  The eMERGE Network is 
ideal for this type of research, as it has the necessary infrastructure and access to a large diverse 
population of individuals who are among those most likely to be invited to participate in a 
biobank.  The overarching aim of the present study was to examine patients’ attitudes towards 
participating in biobank research using an experimental study design that randomly assigned 
participants to different consent and data sharing conditions. 
We hypothesized that participants randomly assigned to a hypothetical biobank with broad 
consent and open data sharing would express less willingness to participate in, and have more 
negative attitudes towards, the biobank than those assigned to a biobank with tiered consent and 
controlled data sharing.  We also hypothesized that willingness would be lower among participants 
of lower socioeconomic status and from underserved racial and ethnic groups.  In addition, we 
examined participants’ perceived benefits, concerns, and information needs regarding participating 
in biobank research.   
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SUBJECTS AND METHODS 
 
Study design and procedures  
This was an experimental survey study.  Individuals were randomly assigned to one of three 
conditions and completed self-report questionnaires.  Participants were patients who had: (1) 
sought care for themselves or their minor child at one of 11 eMERGE Network sites26 between 
October 1, 2013 and September 1, 2014; (2) a valid address that could be geocoded; and (3) age 
and sex available in the electronic health record.  To maximize diversity of the sample, and 
specifically to enrich the observed sample with demographic groups that have been 
underrepresented in previous studies, we utilized a disproportionate stratified sampling scheme. 
Strata were defined by the cross-classification of patient age group (at adult centers: ≤35 years 
and >35 years; pediatric centers: ≤12 years and >12 years), sex, race (White, Black, Asian, Native 
American/Alaska Native, Hawaiian/Pacific Islander, Other), ethnicity (Hispanic/Latino or not), 
education group (<12 years, 12-15 years, 16+ years), and residence in a rural vs. urban/suburban 
census block group.  To be able to execute this complex study design, values for each stratification 
variable needed to be known (or estimated) prior to randomization. Many of these items, as well as 
home address, were readily available in the EHR.  Others were incomplete or were inaccurate.  
Home addresses were geocoded and linked to unique census block groups.  Information from the 
2010 census and 2008-2012 American Community Survey were used to impute missing 
stratification information, using the mode of the participant’s census block group value, in order to 
define the ‘approximate’ sampling frame.  Further details on the sampling frame and the stratified 
sampling strategy are provided in Table S1 and Table S2.  A thorough exposition of the sampling 
scheme, including how census data were utilized for the purpose of sampling, are provided in an 
upcoming journal article.  The sampling frame was approximately 2.4 million patients of whom 
90,000 were selected.  
Participants within each sampling stratum were randomized to receive a survey which 
included one of three hypothetical biobank scenarios.  The scenarios were identical except for the 
details regarding consent type and data sharing approach.27  In the first scenario, donated samples 
and data could be used for all kinds of medical research and data could be shared with approved 
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investigators only (‘broad-controlled’).  The second and third scenarios contained an alternative 
consent approach or data sharing policy: in the ‘tiered-controlled’ scenario, the consent process 
allowed participants to select the types of research for which their samples and data could be 
used; and in the ‘broad-open’ scenario, the data sharing policy allowed de-identified data to be 
shared through an online database open to the public.  
Pre-notification postcards were mailed, after which optical scan surveys were mailed along 
with a non-contingent pre-incentive $2 bill, to potential participants in April 2015.  Non-respondents 
received a reminder letter in May 2015 and a second survey in July 2015.  Participants could 
complete the survey on paper and return it in a self-addressed stamped envelope or complete an 
identical survey through a secure, online survey interface on the REDCap database platform.28 
 
Development of the survey instrument  
The survey instrument, including the three hypothetical scenarios and the survey questions, was 
developed by a multidisciplinary expert working group, informed by the findings from a systematic 
review of the literature.22  A complete draft of the survey instrument content was tested and refined 
using cognitive interviews with 40 patients across six sites.  A pilot study to test the feasibility of the 
survey instrument and study procedures was then conducted across all 11 sites.  In the pilot study, 
166 respondents returned the survey, out of 1500 patients who were sent the survey (response 
rate 11%).  Analysis of pilot data suggested that planned study procedures were robust, and 
quality indicators including incomplete surveys and straight-lined responses necessitated only 
minor revisions to the survey.  Respondents to the pilot survey were excluded from the main study, 
and responses to the pilot were not included in the main analysis.   
 
Survey measures  
Demographics  Standard measures of demographic characteristics were used.29; 30  Poverty was 
calculated from income and number of people in household. Rurality was assessed using census-
level data.  Religiosity was assessed using an item adapted from previous research.31  Self-rated 
health, an indicator of quality of life, was assessed using the widely-used single item from the SF-
12.32 
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Trust and privacy  Concern about privacy was assessed using two items.33  Trust was assessed 
with two items.34; 35  
Willingness to participate  Willingness to participate in the hypothetical biobank described was 
assessed using a single item adapted from previous research.25; 36   
Attitudes towards participating   
Attitude items were either generated specifically for this study, or adapted from previous 
research.24; 25; 37-40  In order to generate these items, the multidisciplinary expert working group 
defined three relevant sub-domains to be assessed within the overarching domain of ‘attitudes 
towards participating in a biobank’: perceived benefits of participating in the described biobank, 
concerns about participating in the described biobank, and information needs about the 
governance of the described biobank (e.g. how decisions are made regarding the use of the 
samples and data).  Initial lists of items to assess each of these sub-domains were compiled based 
on a review of the literature on these topics22 and on expert input.  The lists were culled in an 
iterative manner, in order to produce a manageable number of prioritized items that would not 
over-burden participants.  The final list comprised five items assessing perceived benefits, six 
items assessing concerns, and eight items assessing information needs.  Likert-style scales were 
used with 5 responses ranging from ‘strongly disagree’ to ‘strongly agree’ for each item.  Factor 
analysis confirmed that benefits, concerns and information needs were distinct factors, with all 
items from each set loading on that factor with eigenvalues greater than 0.4.  In order to describe 
responses to these items, responses were dichotomized and proportions responding ‘agree’ or 
‘strongly agree’ with each statement were reported.  In addition, composite scale scores were 
created by calculating the mean of each set of items (possible range from 1 to 5). Mean scores 
were described for each attitudinal scale.  In addition, for the purposes of the regression analysis 
(see below), participant’s scale scores were categorized: scale scores ranging from 1.0 to 2.50 
were categorized as ‘low’; scale scores ranging from 2.51 to 3.50 were categorized as 
‘intermediate’; and scale scores ranging from 3.51 to 5.0 were categorized as ‘high’.  The three 
survey instruments are available online (see Web resources).   
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Data analysis 
Response rates were calculated according to American Association for Public Opinion Research 
(AAPOR) criteria.41  To determine if randomization was maintained within the subset of 
respondents, sample counts and percentages were calculated for socio-demographic variables.  
These summaries were computed within consent and data sharing models across all sites and 
compared using the Pearson’s Chi-Square test. For all other analyses, each participant was 
assigned a post-stratified, sampling weight (i.e., the inverse of the probability of being sampled and 
answering the survey) to account for the stratified sampling design. Because understudied 
populations were intentionally oversampled, sampling weights varied dramatically within and 
across sites, and so we conducted site-specific weight trimming and redistribution combining two 
commonly used approaches: weights were trimmed at (1) the 90th percentile of weights, or (2) the 
median+6*IQR, whichever was higher.42; 43  Recognizing that all trimming approaches are ad hoc, 
we conducted sensitivity analyses for the primary analysis using a number of approaches to 
trimming. Results from sensitivity analyses can be found in Table S3. 
The impact of consent and data sharing models on willingness to participate in biobank 
research was estimated with a (survey weighted) three-level multinomial logistic regression 
(probably not / definitely not; not sure; yes probably / yes definitely) with linearized covariance 
estimates of uncertainty. For ease of exposition, all combined estimates (across multiply imputated 
datasets within a site and then across sites) were transformed and are reported as probabilities (or 
percentages). Comparisons among data sharing and consent models were performed via a Wald-
test from an ordinal logistic regression, proportional odds model. Similar methods were applied to 
estimate the impact of consent and data sharing models on each of the three attitudinal constructs 
(perceived benefits, concerns, and information needs). 
To identify demographic and other characteristics associated with willingness to participate 
in biobank research, willingness was dichotomized (yes = agree / strongly agree; no = not sure /  
disagree / strongly disagree), and was regressed on covariates using unadjusted (marginal) and 
adjusted logistic regression analyses. Adjusted models were fitted hierarchically using socio-
demographic variables first; adding trust and privacy items second; and adding the attitudinal 
constructs third.  Unadjusted estimates were summarized with percentages, and adjusted 
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estimates of covariates associations with willingness to participate were summarized with odds-
ratios and associated 95% confidence intervals. Sub-domain analyses were performed to quantify 
the extent to which the relationship between survey type and willingness differed across socio-
demographic variables. There was little to no evidence to suggest that such interactions existed 
(not shown). Responses to the individual attitudinal items were described, and 95% confidence 
intervals were computed.  
Multiple imputation was conducted within each site to account for item non-response, which 
ranged from less than 1% to 5% for all key variables except income (8%). We used socio-
demographic variables, biobank participation willingness, attitudinal constructs, and deciles of 
post-stratified weights to impute all missing data.44 Ten complete imputation data sets were 
created for each site.  Survey weighted regression analyses were performed on each complete 
data set and combined using the standard ‘Rubin’s rules’.45 For every analysis, site-specific 
estimates were then combined to summarize characteristics of the entire eMERGE Network using 
multivariate random-effect, meta-analytic methods.46  All analyses were performed using R Version 
3.2.2 (R Project for Statistical Computing) and Stata Version 14 (StataCorp).    
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RESULTS  
 
Participant characteristics 
Socio-demographics  Of 90,000 surveys mailed, 7,672 individuals were ineligible due to invalid 
address, death, or incapacity, and 681 refused to participate.  Of the 82,328 eligible individuals, 
exactly 13,000 responded (AAPOR reponse rate 15.8%).  Among responders, 11,712 completed 
the paper (91.9%) and 1,288 the online (9.9%) survey.  Sixty-three percent of participants were 
female; 51% self-identified as White; 18% as Hispanic; 42% had less than a Bachelors degree; 
and 44% had an annual household income of $60,000 or less (Table 1).  There were no 
sociodemographic differences among participants receiving each of the three scenarios, indicating 
randomization was successful.  
Trust and privacy  Ninety percent of participants agreed health information privacy was important 
to them; 64% agreed that they worried about the privacy of their health information.  Two thirds 
agreed that they trusted their healthcare system (64%) and medical researchers (61%). There 
were no differences in participants’ trust and privacy among the three biobank scenario groups 
(Table 2).   
 
Willingness compared between scenario groups  
Overall, 66% (95% CI: 63-69%) of participants stated that they would be willing to participate in the 
biobank described to them (Table 3). Willingness did not differ between broad and tiered consent 
models (68% vs. 66%, χ2=1.07, p=0.30).  Willingness was slightly higher among participants 
presented with a controlled rather than an open data sharing model, although the difference was 
not large in absolute terms (68% vs. 65% respectively, χ2=4.48, p=0.03).  
 
Attitudes compared between scenario groups  
Mean attitude scores (where 1 indicates low, 5 indicates high) were 3.85 for perceived benefits, 
3.11 for concerns, and 3.95 for information needs overall.  Mean scores did not differ between 
experimental conditions (see Table 3).     
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Associations between willingness and participant characteristics  
Because patterns of associations between socio-demographic variables and willingness were the 
same within each of the consent and data sharing conditions separately, and because willingness 
did not differ at the .001 level between groups, all subsequent analyses were conducted on the 
sample as a whole.   
The following participant characteristics were independently associated with willingness to 
participate before attitudes were entered into the model: race (as self-reported by the respondent 
in the survey), education, religiosity, and trust and privacy concerns (Table 4). Black or African 
American participants expressed the lowest levels (56%) and White participants the highest levels 
(70%) of willingness to participate (OR 0.59, 95% CI: 0.47 to 0.76).  Participants who reported 
education “up to some high school” were less willing to participate (51%) than participants with 
doctoral training (76%) (OR 0.47, 95% CI: 0.33 to 0.67).  “Very religious” participants were less 
willing to participate (63%) than “not at all religious” participants (73%) (OR 0.68, 95% CI: 0.54 to 
0.85).  Participants with lower levels of trust in medical researchers and/or their healthcare system, 
those who felt more strongly that the privacy of their health information was important, and those 
more worried about the privacy of their health information were less willing to participate.  
When attitudes toward the biobank were entered into the model, each of the three 
composite scale variables was independently associated with willingness: participants were more 
willing to participate if they perceived more benefits, fewer concerns, and had fewer information 
needs (Table 4).  In this model, education and religiosity remained associated with willingness, but 
race, trust and privacy concerns did not.   
 
Benefits, concerns, and information needs  
The most endorsed benefit in the sample overall was, “I would feel that I was helping future 
generations” (84%, 81-87%), the least endorsed benefit was “I would feel that taking part could 
help me personally” (44%, 40-47%).  The most endorsed concern was, “I would worry about my 
privacy” (51%, 47-55%); the least endorsed concern was, “I would worry that someone might make 
money using my health information” (36%, 33-39%).  The most endorsed information need about 
biobank governance was, “I would want to know what would happen if a researcher misused the 
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health information in the biobank” (86%, 84-87%); the least endorsed information need about 
biobank governance was, “I would want to know if my health information might be used by drug 
companies that make money” (59%, 56-61%) (Table 5). 
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DISCUSSION  
 
This is the largest survey of patients’ attitudes towards participating in biobank research to date.  In 
this study, we found no evidence to support the hypothesis that asking potential biobank 
participants to provide broad consent or permit open data sharing would lead to less willingness to 
participate than asking them to provide tiered consent or permit controlled data sharing.  Models of 
consent and data sharing had limited relevance to participants’ decision-making when they were 
asked to make a decision about whether to participate in the single biobank scenario presented to 
them.  These findings are consistent with previous research reporting that overall acceptance of 
broad consent is similar to that of specific or tiered consent, although a number of factors may 
influence this preference.23-25  Our use of an experimental design and randomization means 
participants were presented with a decision that was closer to the real world than previous studies 
that have given participants choices and asked which consent model they preferred.  Individuals 
may have pre-existing global views regarding participating in biobank research (i.e. they are 
generally open to, or generally against, participating), which are not swayed by the consent and 
data sharing models presented to them. It is also possible that many participants did not read the 
scenario carefully, and were therefore responding to the general idea of participating in a biobank 
rather than the specific scenario presented to them. While this should certainly be considered a 
possible limitation of our findings, it is also possible that this lack of attention to detail simulates, in 
some ways, the attention potential biobank participants give to analogous details in a real biobank 
consent document. 
Our findings support the hypothesis that socio-demographic characteristics are associated 
with willingness to participate in biobank research.  Consistent with previous research,47; 48 
willingness to participate in a biobank was significantly lower among participants who self-identified 
as Black or African American and those with lower levels of educational attainment.  Although  
religiosity is difficult to assess, participants who self-identified as more religious on this simple 
measure were less willing to participate.  Little research has previously explored associations 
between religiosity and attitudes regarding biobank participation,49 but other investigations have 
shown religiosity is associated with negative perceptions of the value of science and technology.50-
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53  Our findings support previous indications that certain socio-demographic groups will require 
greater efforts to ensure participation in large research initiatives going forward.  Our results have 
implications particularly for biobanks that plan to rely on recruitment of volunteers, such as the 
PMI, rather than selection to represent the population.  Unless there is an attempt to over-enroll 
underrepresented groups, as we did in our survey study, large studies like the PMI may end up 
with cohort samples that do not adequately represent the US population.  
We also found that, consistent with previous research,23; 37 willingness to participate in 
biobank research was lower among respondents with more concerns about privacy and lower 
levels of trust.  When designing recruitment strategies, researchers and institutions may be able to 
address these trust and privacy concerns at a local level by building relationships with their 
communities, and at a national level by implementing new policies and public education and 
engagement strategies.  We also found, however, that these associations between privacy, trust 
and willingness were no longer statistically significant after attitudes towards biobank research 
(benefits, concerns, information needs about governance) were added in to the model.  This 
further suggests that outreach and engagement conveying the benefits of biobank research, and 
addressing concerns and information needs, may be important and achievable strategies to 
including more diverse populations in these research efforts.   
We found that participants were more concerned about some risks than others, and wanted 
to know more about some aspects of governance than others.  These findings may be of particular 
value to researchers, institutions and organizations involved in developing public education and 
information materials about biobanks, as they shed valuable light on what potential participants 
want to know about research.    
Limitations include a low response rate.  Although this was not unexpected given our 
recruitment method and efforts to oversample populations typically less willing to participate in 
research, we cannot know how much opinions of nonresponders would differ.  However, it seems 
unlikely that nonresponders would be more willing to enroll in biobanks.  Our study also relied on 
participants’ self-reported intentions and hypothetical scenarios, rather than actual behavior.  It is 
also possible that participants did not read all of the hypothetical scenario, and so may not have 
appreciated the detail regarding the consent and data sharing model.  They did, however, have 
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opinions about other aspects of the proposal which suggests substantial engagement with the 
survey.  The limitations need to be weighed against the study’s strengths, which include broad 
geographical and diverse institutional coverage, a rigorous sampling strategy, and experimental 
design.   
In conclusion, the results from this study suggest that biobanks using broad consent may 
not be less successful in recruiting participants than if they use more specific consent approaches.  
Open data sharing may be almost as acceptable to participants as controlled data sharing.  Some 
socio-demographic groups differ in their willingness to participate in biobank research.  Individuals 
discriminate between different positive and negative aspects of biobank participation, and feel 
more strongly about knowing about some aspects of biobank governance than others. Targeted 
interventions designed to recruit underrepresented groups, to make biobank information easier to 
understand, and to address individuals’ specific attitudes about participating in a biobank may help 
increase acceptance of broad consent and open data sharing in biobank research.  These findings 
may be of use to biobank investigators concerned with how biobanks are governed and to policy 
makers working to revise regulations on the protection of human research subjects.   
  
17 
 
SUPPLEMENTAL DATA 
Supplemental Data includes three tables and supplemental references. 
ACKNOWLEDGEMENTS: 
We would like to acknowledge the work of the following: Melissa Basford, Meckenzie Behr, Jess 
Behrens, Laura Beskow, Ariel Chandler, Beth Chau, Rosetta Chiavacci, Kurt Christensen, Beth 
Cobb, Natalia Connolly, Stephanie Devaney, Joe DeWalle, Steve Ellis, Alexander Fiksdal, John 
Harley, Diana Harris, Paul Hitz, Yolanda Keppel,  Nicole Lockhart, Keith Marsolo, Catherine 
MarxKate Nowakowski, Jen Pacheco, Josh Pankratz, Lisa Price,  Michelle Ramos, Sarah 
Stallings, Allise Taran, Matt Verkemp,  Gordon Willis, and Sonja Ziniel. 
 
The CERC Survey project within the eMERGE Network was initiated and funded by NHGRI with 
additional funding by the NIH Office of the Director through the following grants: U01HG006828 
(Cincinnati Children’s Hospital Medical Center/Boston Children’s Hospital); U01HG006830 
(Children’s Hospital of Philadelphia); UOIHG006389 (Essentia Institute of Rural Health, Marshfield 
Clinic Research Foundation and Pennsylvania State University); U01HG006382 (Geisinger Clinic); 
U01HG006375 (Group Health Cooperative/University of Washington); 3U01HG006379 (Mayo 
Clinic); U01HG006380 (Icahn School of Medicine at Mount Sinai); 3U01-HG006388 (Northwestern 
University); U01HG006378 (Vanderbilt University Medical Center); and 3U01HG0006385 
(Vanderbilt University Medical Center serving as the Coordinating Center). 
  
18 
 
Table 1. Sociodemographic and health characteristics of survey respondents by consent and data sharing 
model and across models   
 Broad-
controlled 
Broad- 
open 
Tiered-
controlled 
Overall 
 N % N % N % N % 
Total 4405 34% 4371 34% 4224 32% 13,000 100% 
Sex         
Female 2734 63% 2739 64% 2601 63% 8074 63% 
Male 1583 37% 1561 36% 1557 37% 4701 37% 
Age         
18-35 years 1058 25% 1023 24% 1030 25% 3111 25% 
36-50 years 1364 32% 1339 32% 1317 32% 4020 32% 
51-64 years 1019 24% 1042 25% 942 23% 3003 24% 
65+ years 823 19% 822 19% 790 19% 2435 19% 
Race         
White 2197 51% 2202 52% 2122 52% 6521 51% 
Asian 746 17% 718 17% 742 18% 2206 17% 
Black or African American 506 12% 501 12% 476 12% 1483 12% 
Other 438 10% 405 9% 385 9% 1228 10% 
American Indian or Alaska Native 223 5% 245 6% 221 5% 689 5% 
More than one race 148 3% 155 4% 119 3% 422 3% 
Native Hawaiian or Pacific Islander 45 1% 49 1% 47 1% 141 1% 
Ethnicity         
Latino 785 18% 758 18% 725 18% 2268 18% 
Not Hispanic/Latino 3507 82% 3476 82% 3365 82% 10348 82% 
Educational attainment         
Up to some high school (grades 9-12) 328 8% 279 7% 282 7% 889 7% 
High school graduate or GED 459 11% 465 11% 471 12% 1395 11% 
Some college 1026 24% 1060 25% 965 24% 3051 24% 
Bachelors degree or equivalent 1180 28% 1166 28% 1132 28% 3478 28% 
Masters degree or equivalent 767 18% 778 19% 772 19% 2317 19% 
PhD / MD / JD or equivalent 452 11% 438 10% 443 11% 1333 11% 
Annual household income         
Less than $30,000  902 22% 915 23% 889 23% 2706 23% 
$30,000 - $60,000  838 21% 847 21% 778 20% 2463 21% 
$60,000 - $90,000 599 15% 644 16% 650 17% 1893 16% 
$90,000 to $150,000 852 21% 781 19% 785 20% 2418 20% 
More than $150,000 864 21% 866 21% 804 21% 2534 21% 
Total number of people in household          
1 551 13% 584 14% 498 12% 1633 13% 
2 1281 30% 1316 31% 1260 31% 3857 30% 
3 826 19% 805 19% 758 18% 2389 19% 
4 or more 1623 38% 1550 36% 1604 39% 4777 38% 
Povertya         
Below the poverty line 586 15% 615 15% 590 15% 1791 15% 
Not below the poverty line 3422 85% 3391 85% 3273 85% 10086 85% 
Work situation         
Working  2313 53% 2288 53% 2233 54% 6834 53% 
Retired  796 18% 805 19% 785 19% 2386 19% 
Disabled / Unemployed 496 11% 493 11% 471 11% 1460 11% 
Other 741 17% 725 17% 679 16% 2145 17% 
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 Broad-
controlled 
Broad- 
open 
Tiered-
controlled 
Overall 
 N % N % N % N % 
Healthcare insurance         
Private insurance 3061 71% 3011 71% 2948 71% 9020 71% 
Public insurance 1051 24% 1065 25% 1003 24% 3119 25% 
Other type of insurance 102 2% 98 2% 91 2% 291 2% 
No insurance 87 2% 82 2% 94 2% 263 2% 
Rurality (from census-level data)         
Suburban / Urban 2549 58%  2530 58%  2427 57% 7506 58% 
Rural 1856 42%  1841 42%  1797 43% 5494 42% 
Marital status          
Married, living with someone 2696 63% 2701 64% 2630 64% 8027 64% 
Not married, living with someone 352 8% 333 8% 350 9% 1035 8% 
Not married, not living with someone 1201 28% 1164 28% 1112 27% 3477 28% 
Number of children          
No children 862 20%  850 20%  838 21% 2550 20% 
One or more child 3398 80% 3384 80% 3246 79% 10028 80% 
Parent of child less than 18yrs of age         
No 2508 57%  2480 57%  2344 55% 7332 56% 
Yes 1897 43%  1891 43%  1880 45% 5668 44% 
Religiosity           
Not at all religious 615 14%  603 14%  591 14%  1809 14% 
Not very religious 684 16%  660 15%  660 16%  2004 16% 
Somewhat religious 1881 44%  1836 43%  1827 44%  5544 44% 
Very religious 1131 26%  1172 27%  1057 26% 3360 26% 
Self-rated health         
Excellent 544 13% 558 13% 501 12% 1603 13% 
Very good 1364 31% 1345 31% 1287 31% 3996 31% 
Good 1606 37% 1569 37% 1589 38% 4764 37% 
Fair 659 15% 660 15% 660 16% 1979 15% 
Poor  168 4% 151 4% 133 3% 452 4% 
Diagnosis of a genetic disorder         
No 3795 93% 3783 95% 3664 94% 11242 94% 
Yes 264 7% 218 5% 248 6% 730 6% 
aFederal poverty level guidelines were used to assign poverty status and are a function of income and 
number of individuals within a household (below poverty line = 1 if income < number in 
household*4160+11770) (Department of Health and Human Services).54 Categorized income levels were 
collected in the survey and thus interval midpoints were used as a proxy for income in the threshold 
formula.  
Note: Observed frequencies and percentages are reported ignoring sampling design.  Pearson’s Chi-
Square tests were performed to assess differences between consent and data sharing models and each 
characteristic; no differences were detected and thus for brevity test summaries were omitted, but available 
from the authors.  
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Table 2. Trust in the healthcare system, trust in medical researchers, and concerns about privacy of 
survey respondents by consent and data sharing model and across models   
 
Broad-
controlled 
Broad- 
open 
Tiered-
controlled 
Overall 
 N % N % N % N % 
 
Privacy 
 
Health information privacy is 
important to me 
        
Disagree / Strongly disagree 117 3%  96 2%  100 2% 313 2% 
Neither agree nor disagree  332 8%  327 8%  344 8% 1003 8% 
Agree / Strongly agree 3861 90%  3850 90%  3686 89% 11397 90% 
I worry about the privacy of my health 
information 
        
Disagree / Strongly disagree 705 16%  671 16%  678 16% 2054 16% 
Neither agree nor disagree  856 20%  822 19%  838 20% 2516 20% 
Agree / Strongly agree 2745 64%  2783 65%  2607 63% 8135 64% 
Trust 
 
I trust my healthcare system 
        
Disagree / Strongly disagree 522 12%  499 12%  471 11% 1492 12% 
Neither agree nor disagree  1018 24%  1049 25%  1021 25% 3088 24% 
Agree / Strongly agree 2778 64%  2726 64%  2637 64% 8141 64% 
I trust medical researchers         
Disagree / Strongly disagree 301 7%  325 8%  279 7% 905 7% 
Neither agree nor disagree  1336 31%  1362 32%  1306 32% 4004 32% 
Agree / Strongly agree 2648 62%  2565 60%  2535 62% 7748 61% 
Observed frequencies and percentages are reported ignoring sampling design.  Pearson’s Chi-Square 
tests were performed to assess differences between consent and data sharing models and each 
characteristic; no differences were detected and thus for brevity test summaries were omitted, but 
available from the authors. 
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Table 3. Willingness and attitudes (composite perceived benefits, concerns, and information needs) towards participating in a biobank by consent and 
data sharing model and across models  
  
Biobank consent and data sharing model 
 
   
 
Broad-controlled 
(BC) 
Broad-open        
(BO)  
 
Tiered-controlled 
(TC) 
 
All  BC vs BO 
 
BC vs TC 
 N %  N % N % N %   
Primary Outcome           
Willingness to participate in a 
biobank  
          
No definitely not / Probably not  513 12 (10,14) 611  15 (13,18) 487 12 (9,15) 1611 13 (12,15) X12=4.48, 
p=0.03 
X12=1.07, 
p=0.30 Not sure  853 20 (17,22) 913  20 (17,23) 853 22 (19,25) 2619 20 (19,22) 
Yes probably / Yes definitely  2880  68 (65,72) 2702 65 (61,69) 2758 66 (62,71) 8340 66 (63,69) 
Secondary Outcomes           
Perceived benefits            
Low (1.0-2.5)  143 4 (3,5) 147  4 (3,5) 146 3 (2,5) 436 4 (3,5) X12=0.70, 
p=0.79 
X12=1.42, 
p=0.23 Intermediate (2.5-3.5) 887 21 (18,23) 926  22 (19,25) 934 23 (20,27) 2747 22 (20,24) 
High (3.5-5.0)  3164  75 (72,78) 3063 75 (71,78) 2952 73 (69,77) 9179 74 (72,77) 
Concerns            
Low (1.0-2.5)  1321 34 (30,38) 1231  32 (28,37) 1305 34 (29,39) 3857 33 (30,37) X12=1.23, 
p=0.27 
X12=0.06, 
p=0.80 Intermediate (2.5-3.5) 1263 30 (28,33) 1243 30 (27,33) 1175 30 (28,32) 3681 30 (29,32) 
High (3.5-5.0)  1520  36 (32,40) 1636 38 (34,42) 1479 36 (32,40) 4635 36 (33,40) 
Information needs            
Low (1.0-2.5)  176 5 (3,6) 179  6 (5,8) 190 5 (3,6) 545 5 (4,6) X12=0.08, 
p=0.77 
X12=1.30, 
p=0.25 Intermediate (2.5-3.5) 831 22 (19,24) 695 19 (17,21) 767 19 (17,22) 2293 20 (18,22) 
High (3.5-5.0)  3161  74 (71,77) 3267 75 (72,78) 3087 76 (72,80) 9506 75 (72,77) 
Secondary outcomes were defined as the average of the recoded survey items (1= No, definitely not, …, 5=Yes, definitely) that comprised the 
outcomes. Observed frequencies and survey-adjusted percentages (95% CI) are reported for all outcomes. Wald tests were performed to assess 
differences between data sharing models (broad-controlled, BC, vs broad-open, BO) and between consent types (broad-controlled vs tiered-controlled).   
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Table 4. Univariate and multivariate associations between consent and data sharing models, socio-
demographics, trust and privacy items, and attitudinal constructs and willingness to participate in a biobank  
     
Multivariate models, OR (95% CI) 
 
Independent 
variable 
Percent  
(95% CI) 
Socio-
demographics 
Socio-
demographics, 
trust & privacy 
Socio-demographics, 
trust & privacy  
& attitudes  
Consent & data sharing model     
 Broad-controlled 68 (65, 71) 1 1 1 
 Broad-open 65 (62, 68) 0.84 (0.68, 1.03) 0.81 (0.66, 1.00) a 0.80 (0.63, 1.02) 
 Tiered-controlled 66 (61, 70) 0.94 (0.76, 1.17) 0.93 (0.69, 1.24) 0.90 (0.66, 1.22) 
Sex     
 Female 66 (63, 69) 1 1 1 
 Male 67 (63, 71) 0.92 (0.76, 1.11) 0.87 (0.72, 1.07)  0.91 (0.73, 1.13) 
Age     
 18-35 years 65 (61,70) 1.05 (0.81, 1.35) 0.92 (0.65, 1.30)  0.97 (0.70, 1.34) 
 36-50 years 65 (61,68) 1 1 1 
 51-64 years 66 (62,70) 1.06 (0.76, 1.46) 0.99 (0.64, 1.53)  0.91 (0.59, 1.40) 
 65+ years 70 (65,75) 1.01 (0.63, 1.62) 0.80 (0.43, 1.50)  0.79 (0.39, 1.58) 
Race     
 White 70 (67,74) 1 1 1 
 Black or African American 56 (51,60) 0.59 (0.47, 0.76)a 0.68 (0.52, 0.88) a 0.74 (0.53, 1.04) 
 Asian 60 (54,66) 0.62 (0.49, 0.76)a 0.67 (0.53, 0.84) a 0.79 (0.59, 1.04) 
 American Indian or Alaska Native 57 (49,65) 0.70 (0.51, 0.95)a 0.78 (0.57, 1.05)  0.81 (0.57, 1.15) 
 Otherb 56 (49,63) 0.67 (0.49, 0.94)a 0.82 (0.46, 1.46) 0.89 (0.61, 1.31) 
 More than one race 65 (56,73) 0.83 (0.54, 1.27) 0.90 (0.60, 1.35)  1.10 (0.67, 1.81) 
Ethnicity     
 Latino 67 (64, 70) 1 1 1 
 Not Hispanic/Latino 61 (55, 66) 0.94 (0.71, 1.24) 0.91 (0.59, 1.40) 0.89 (0.66, 1.21) 
Educational attainment     
 Up to some high school (grades 9-12) 51 (44, 57) 0.47 (0.33, 0.67)a 0.40 (0.26, 0.59) a 0.34 (0.21, 0.54) a 
 High school graduate or GED 58 (53, 64) 0.63 (0.43, 0.93)a 0.60 (0.39, 0.90) a 0.52 (0.33, 0.84) a 
 Some college 64 (60, 68) 0.78 (0.58, 1.04) 0.79 (0.56, 1.12)  0.62 (0.44, 0.88) a 
 Bachelors degree or equivalent 70 (67, 73) 0.83 (0.60, 1.14) 0.83 (0.58, 1.18)  0.75 (0.52, 1.08) 
 Masters degree or equivalent 73 (68, 77) 0.96 (0.73, 1.28) 0.96 (0.73, 1.28)  0.91 (0.64, 1.29) 
 PhD / MD / JD or equivalent 76 (70, 81) 1 1 1 
Annual household income     
 Less than $30,000  56 (52,60) 0.58 (0.42, 0.79)a 0.67 (0.46, 0.97)a  0.74 (0.48, 1.13) 
 $30,000 - $60,000  63 (58,67) 0.66 (0.43, 0.93)a 0.71 (0.52, 0.96)a 0.81 (0.57, 1.13) 
 $60,000 - $90,000 68 (64,72) 0.84 (0.63, 1.13) 0.89 (0.63, 1.25) 0.99 (0.68, 1.43) 
 $90,000 to $150,000 74 (70,77) 1.12 (0.83, 1.50) 1.11 (0.85, 1.46) 1.15 (0.83, 1.61) 
 More than $150,000 73 (68,77) 1 1 1 
Total number of people in household      
 1 84 (66, 94) 2.23 (0.68, 7.32) 2.77 (0.29, 26.80) 2.08 (0.38, 11.48) 
 2 68 (63, 72) 1.10 (0.87, 1.40) 1.10 (0.79, 1.53) 1.12 (0.79, 1.58) 
 3 66 (62,69) 1.01 (0.81, 1.25) 1.09 (0.83, 1.43) 1.10 (0.85, 1.43) 
 4 or more 65 (62,68) 1 1 1 
Work situation     
 Working  67 (64,70) 1 1 1 
 Retired  69 (65,73) 1.24 (0.94, 1.64) 1.22 (0.90, 1.66) 1.10 (0.73, 1.66) 
 Disabled / Unemployed 60 (55,65) 0.90 (0.70, 1.16) 0.99 (0.77, 1.28) 0.98 (0.70, 1.37) 
 Other 64 (59,68) 0.97 (0.75, 1.26) 1.00 (0.65, 1.53) 0.95 (0.66, 1.37) 
Healthcare insurance     
 Private insurance 67 (64,71) 1 1 1 
 Public insurance 64 (60,69) 1.45 (1.04, 2.03)a 1.33 (0.96, 1.84) 1.37 (0.89, 2.12) 
 Other type of insurance 59 (49,68) 1.05 (0.65, 1.68) 0.95 (0.57, 1.58) 1.09 (0.63, 1.87) 
 No insurance 63 (54,71) 1.79 (1.08, 2.96)a 1.79 (1.00, 3.23)a 1.65 (0.81, 3.35) 
Rurality (from census-level data)     
 Suburban / Urban 66 (63,70) 1 1 1 
 Rural 67 (64,71) 0.94 (0.79, 1.11) 0.95 (0.80, 1.13) 0.99 (0.77, 1.27) 
Marital status      
 Married, living with someone 69 (65,72) 1 1 1 
 Not married, living with someone 68 (63,72) 1.08 (0.79, 1.47) 1.08 (0.76, 1.54) 0.95 (0.67, 1.35) 
 Not married, not living with someone 61 (56,66) 0.91 (0.71, 1.17) 0.88 (0.66, 1.19) 0.86 (0.60, 1.25) 
Religiosity       
 Not at all religious 73 (69,77) 1 1 1 
 Not  very religious 71 (67,74) 0.89 (0.68, 1.16) 0.85 (0.64, 1.13) 0.68 (0.48, 0.97)a 
 Somewhat religious 65 (61,69) 0.74 (0.59, 0.93)a 0.73 (0.56, 0.96) a 0.62 (0.46, 0.83) a 
 Very religious 63 (59,66) 0.68 (0.54, 0.85)a 0.68 (0.53, 0.88) a 0.59 (0.44, 0.80) a 
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Multivariate models, OR (95% CI) 
 
Independent 
variable 
Percent  
(95% CI) 
Socio-
demographics 
Socio-
demographics, 
trust & privacy 
Socio-demographics, 
trust & privacy  
& attitudes  
I trust my healthcare system 
 Disagree  48 (43,54) - 0.73(0.55, 0.98)a 1.02 (0.70, 1.47) 
 Neither  56 (53,60) - 0.81 (0.60, 1.08) 0.95 (0.69, 1.29) 
 Agree  74 (71,77) - 1 1 
I trust medical researchers     
 Disagree  34 (29,41) - 0.18 (0.13, 0.25)a 0.52 (0.36, 0.75)a 
 Neither  52 (49,55) - 0.38 (0.30, 0.49)a 0.61 (0.47, 0.80)a 
 Agree  78 (75,80) - 1 1 
Health information privacy is important to me     
 Disagree  76 (67,83) - 1.10 (0.63, 1.94) 1.18 (0.80, 2.25) 
 Neither  80 (75,84) - 1.47 (1.02, 2.13) a 1.14 (0.80, 1.64) 
 Agree  65 (61,68) - 1 1 
I worry about the privacy of my health information     
 Disagree  87 (85,89) - 3.64 (2.63, 5.02) a 1.44 (1.01, 2.07)a 
 Neither  77 (74,80) - 2.15 (1.64, 2.83) a 1.10 (0.81, 1.49) 
 Agree  57 (53,61) - 1 1 
Perceived benefits of participating in a biobank     
 Low (1.0-2.5)  6 (3, 10) - - 1 
 Intermediate (2.5-3.5) 32 (29,36) - - 8.10 (3.47, 18.90)a 
 High (3.5-5.0)  80 (77,82) - - 62.21 (28.72, 134.75)a 
Concerns about participating in a biobank     
 Low (1.0-2.5)  91 (90,93) - - 1 
 Intermediate (2.5-3.5) 76 (72,80) - - 0.32 (0.24, 0.43)a 
 High (3.5-5.0)  40 (37,43) - - 0.07 (0.05, 0.10)a 
 
Information needs about participating in a biobank 
    
 Low (1.0-2.5)  76 (68,82) - - 1 
 Intermediate (2.5-3.5) 78 (73,82) - - 1.36 (0.88, 2.09) 
 High (3.5-5.0)  62 (59,65) - - 1.62 (1.02, 2.58)a 
      
adenotes significant differences at the 0.05 level.  
bDue to small cell counts, Native Hawaiian/Pacific Islanders were grouped with the Other racial category.  
Survey-adjusted logistic regression estimates from the univariate models have been transformed to percentages (95% 
CI) while odds ratios (OR, 95% CI) summarize multivariate models. 
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Table 5. Attitudes (specific perceived benefits, concerns, and information need) towards participating 
in a biobank   
Attitudes  
 
 
N 
Agree / 
strongly 
agree                       
Percent 
(95% CI) 
Perceived benefits of participating in a biobank   
I would feel that I was helping future generations.   10773 84 (81, 87) 
I would feel that taking part could lead to better medical treatments. 10564 83 (80, 85) 
I would feel that taking part would help doctors where I get my medical care take 
better care of patients. 
9957 78 (75, 80) 
I would feel that taking part could help my family. 8139 65 (62, 67) 
I would feel that taking part could help me personally. 5667 44 (40, 47) 
Concerns about participating in a biobank    
I would worry about my privacy. 6578 51 (47, 55) 
I would worry about my medical record being shared. 5903 45 (42, 49) 
I would worry about how researchers would use my health information. 5404 41 (38, 45) 
I would worry about my genetic information being shared. 4866 38 (34, 41) 
I would worry that some research would be done that I did not want to take part in. 4713 37 (34, 40) 
I would worry that someone might make money using my health information. 4856 36 (33, 39) 
Information needs regarding governance of a biobank   
I would want to know what would happen if a researcher misused the health 
information in the biobank. 
11055 86 (84, 87) 
I would want to know what kind of knowledge would result from the use of my 
health information.  
10827 84 (82, 86) 
I would want to know who makes sure that my health information is used in the 
right way.  
10752 84 (81, 86) 
I would want to know if my health information might be used by insurance 
companies.   
10160 79 (77, 81) 
I would want to know the types of research my health information would be used for. 9748 74 (71, 77) 
I would want to know who runs the biobank.  9500 73 (71, 75) 
I would want to know how the biobank covers costs. 7716 60 (57, 62) 
I would want to know if my health information might be used by drug companies 
that make money. 
 
7625 59 (56, 61) 
Each item was dichotomized (1=agree or strongly agree, 0=otherwise) and the observed frequencies and 
ordered survey-adjusted percentages (95%CI) are reported.  Differences were not detected between data 
sharing and consent models on the construct level (Table 3) and thus only overall summaries are provided. 
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Web resources 
 
The URL for the survey instruments used in this study can be found here:  
https://emerge.mc.vanderbilt.edu/projects/emerge-cerc-survey-2/    
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